ATM and lung carcinoma: The ATM-L2307F was found in 4.43% (MAF = 0.023) individuals from lung cancer case control study from Israel, slightly higher in North Americans (MAF = 0.002) and close to monomorphic in other European countries (Supplementary Table 7).